Who owns CYCLERION THERAPEUTICS INC COM?
- Ticker: CYCN
- CUSIP Number: 23255m204
Tip: Access positions for across all investors
Analyze quarterly positions in Cyclerion Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Cyclerion Therapeutics stock
Who bought or sold CYCLERION THERAPEUTICS INC COM this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Tyndall Capital Partners | 164k | $551k | 11% | Dec 2023 |
|
Artal Group | 139k | $466k | 0% | Dec 2023 |
|
Vanguard Group | 24k | $79k | -42% | Dec 2023 |
|
UBS Group | 2.2k | $7.5k | 707% | Dec 2023 |
|
Royal Bank of Canada | 330.00 | $999.999000 | -64% | Dec 2023 |
|
Advisor Group Holdings | 187.00 | $626.001200 | -1% | Dec 2023 |
|
Wells Fargo & Company | 15.00 | $49.999500 | 7% | Dec 2023 |
|
Who sold out of Cyclerion Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Wolverine Trading | Sep 2023 | 14k | $49k |